Sidoti Downgrades Anika Therapeutics (ANIK) to Neutral
Sidoti analyst James Sidoti downgraded Anika Therapeutics (NASDAQ: ANIK) from Buy ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
